The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Systemic chemotherapy compared with radiation therapy as adjuvant therapy after radical surgery in high-risk stage IB-IIB cervical adenocarcinoma.
Toshiyuki Seki
No relevant relationships to disclose
Hiroshi Tanabe
No relevant relationships to disclose
Chie Nagata
No relevant relationships to disclose
Satoshi Takakura
No relevant relationships to disclose
Seiji Isonishi
No relevant relationships to disclose
Kazuhiko Ochiai
No relevant relationships to disclose
Hiroshi Sasaki
No relevant relationships to disclose
Kazunori Ochiai
No relevant relationships to disclose
Aikou Okamoto
No relevant relationships to disclose